Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals

Atherosclerosis

Volumn 144, Issue 1, 1999, Pages 229-235

  Hanefeld, M ^a   Koehler, C ^a   Schaper, F ^a   Fuecker, K ^a   Henkel, E ^a   Temelkova Kurktschiev, T ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Coronary risk factors; Glucose tolerance; Insulin; Intima media thickness; Postprandial state

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY RISK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEINURIA; SEX DIFFERENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CAROTID ARTERIES; COMORBIDITY; CONFIDENCE INTERVALS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC; TUNICA INTIMA;

EID: 0033013870     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00059-3     Document Type: Article

References (39)

1. Gerstein HG, Yusuf S. Dysglycemia and risk of cardiovascular disease. Lancet 1996;347:949-50.
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall Study. Br Med J 1983;287:867-70.
3. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary heart disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1980;I:1373-6.
4. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992;41:202-8.
5. Wilson PWF, Cupples A, Kannel WB. Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991;121:586-90.
6. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
7. Jarrett RJ, McCartney P, Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982;22:79-84.
8. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-16.
9. Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: Helsinki Policemen Study. J Chron Dis 1979;32:729-45.
10. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83.
11. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
12. Heiss G, Sharett AR, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: association with cardiovscular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-6.
13. Belcaro G, Geroulakos G, Laurora G, et al. Inter/intra-observer variability of carotid and femoral bifurcation intima-media thickness measurements. Panminerva Med 1993;35:75-9.
14. Bots ML, Mulder PG, Hofman A, vanEs GA, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol 1994;47:921-30.
15. Persson J, Stavenow L, Wikstrand J, Israelsson B, Formgren J, Berglund G. Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb 1992;12:261-6.
16. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL. Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 1995;17:1330-6.
17. Yamasaki Y, Kawamori R, Matsushima H, et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994;43:634-9.
18. Kanters SDJM, Algra A, Banga JD. Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients. Diabetes Care 1997;20:276-80.
19. Vitelli LL, Shahar E, Heiss G, et al. Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. Diabetes Care 1997;20:1454-8.
20. Temelkova-Kurktschiev T, Koehler C, Schaper F, et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in nondiabetic individuals. Diabetologia 1998;41:706-12.
21. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
22. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 1994;236:79-84.
23. Pan WH, Bai CH, Chen JR, Chiu HC. Association between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997;28:88-94.
24. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995;9:827-33.
25. Cortellaro M, Baldassarre D, Cofrancesco E, et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease. Stroke 1996;27:450-4.
26. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall IMT is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995;26:956-60.
27. Yamasaki Y, Kawamori R, Matsushima H, et al. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995;38:585-91.
28. Barrett-Connor E. Does hyperglycemia really cause coronary heart disease? Diabetes Care 1997;20:1620-3.
29. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherosclerosis. Diabetes Care 1991;14:839-55.
30. Juhan-Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993;13:1865-73.
31. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension and cardiovscular disease: which role for oxidative stress? Metabolism 1995;44:363-8.
32. Ceriello A, Giacomello R, Stel G, et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress. Diabetes 1995;44:924-8.
33. Yki-Järvinen H. Glucose toxicity. Endocr Rev 1992;13:415-31.
34. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34(6):416-22.
35. Wingard DL, Barrett-Connor E, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care 1995;18:1299-304.
36. Stern MP. Diabetes and cardiovascular disease: The common soil hypothesis. Diabetes 1995;44:369-74.
37. Jarrett PJ. The cardiovascular risk associated with impaired glucose tolerance. Diabetic Med 1996;13:15-9.
38. Buring JE, O'Connor GT, Goldhaber SZ, et al. Decreased HDL2 and HDL3 cholesterol, apo A-I and apo A-II, and increased risk of myocardial infarction. Circulation 1992;85:22-9.
39. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscl Thromb 1991;11:2-14.